red fluorescent protein rfp (Sanofi)
Structured Review
Red Fluorescent Protein Rfp, supplied by Sanofi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/red+fluorescent+protein+rfp/fluorescent+protein+red+rfp/pmc13006415-484-22-27
Average 86 stars, based on 1 article reviews
Images
Related Articles
In Vitro:Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Release Assay:Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Derivative Assay:Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Transfection:Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with Article Title: Targeting BCMA in multiple myeloma with a trifunctional NK cell engager. Article Snippet: .. For the in vitro cytokine release assay, RPMI 8226-RFP cells were derived from RPMI 8226 cells obtained from ATCC and transfected with |
